203 filings
8-K
Horizon Pharmaceutical LLC
31 Oct 16
Material Modifications to Rights of Security Holders
12:00am
8-K
Horizon Pharmaceutical LLC
25 Oct 16
Termination of a Material Definitive Agreement
12:00am
8-K
Horizon Pharmaceutical LLC
19 Oct 16
Departure of Directors or Certain Officers
12:00am
8-K
Horizon Pharmaceutical LLC
11 Oct 16
Entry into a Material Definitive Agreement
12:00am
8-K
Horizon Pharmaceutical LLC
12 Sep 16
Horizon Pharma plc to Acquire Raptor Pharmaceutical Corp. as Further Step
12:00am
8-K
1nfuw62iyr3jv wo
4 Aug 16
Raptor Pharmaceutical Corp. Reports Second Quarter 2016 Financial Results
12:00am
8-K
p41q00qr ogq118v1wl
7 Jul 16
Termination of a Material Definitive Agreement
12:00am
8-K
gd6m03atz 5gfalvlp
27 May 16
Other Events
12:00am
8-K
5bgdp2
13 May 16
Departure of Directors or Certain Officers
12:00am
8-K
sljy1hmq7 7d
5 May 16
Raptor Pharmaceutical Corp. Reports First Quarter 2016 Financial Results
12:00am
8-K
n56p1n 6k6e5
15 Mar 16
Other Events
12:00am
8-K
yc5owngn7n0zp 728r
25 Feb 16
Raptor Pharmaceutical Corp. Reports Fourth Quarter and Full Year 2015 Financial Results and Provides 2016 Corporate Update
12:00am
8-K
r7be9fb3 4q
9 Feb 16
Departure of Directors or Certain Officers
12:00am
8-K
7ymu8kb
10 Dec 15
Other Events
12:00am
8-K
vjxcd
5 Nov 15
Raptor Pharmaceutical Corp. Reports Third Quarter 2015 Financial Results and Provides Corporate Update
12:00am
8-K
9kujkxt
5 Oct 15
Strengthens core position in treatment of rare diseases and provides additional opportunities for growth
12:00am
8-K
rh9wj7
14 Sep 15
Raptor Pharmaceutical Provides Topline Results from Phase 2b CyNCh Study Evaluating RP103 in Pediatric Nonalcoholic Steatohepatitis
12:00am
8-K
raq6e4wjlb mmb
9 Sep 15
Other Events
12:00am
8-K
02jrhw l3f0cjyk
8 Sep 15
Entry into a Material Definitive Agreement
12:00am
8-K
kd0fnlbdjvm
8 Sep 15
Entry into a Material Definitive Agreement
12:00am